Table 2.
Sequence | Population | SG | MG | QX | SN | ML |
---|---|---|---|---|---|---|
Cyt b | SG | — | 0.003 | 0.003 | 0.003 | 0.004 |
MG | −0.038 | — | 0.003 | 0.003 | 0.004 | |
QX | −0.021 | −0.033 | — | 0.003 | 0.004 | |
SN | −0.017 | −0.029 | −0.023 | — | 0.004 | |
ML | 0.179 | 0.160 | 0.195 | 0.139 | — | |
CR | SG | — | 0.007 | 0.007 | 0.007 | 0.009 |
MG | −0.035 | — | 0.007 | 0.007 | 0.009 | |
QX | −0.026 | −0.031 | — | 0.007 | 0.009 | |
SN | −0.026 | −0.032 | −0.023 | — | 0.009 | |
ML | 0.154 | 0.134 | 0.156 | 0.104 | — | |
Cyt b + CR | SG | — | 0.005 | 0.005 | 0.005 | 0.006 |
MG | −0.036 | — | 0.005 | 0.005 | 0.006 | |
QX | −0.024 | −0.032 | — | 0.005 | 0.006 | |
SN | −0.022 | −0.030 | −0.023 | — | 0.006 | |
ML | 0.164 | 0.145 | 0.172 | 0.119 | — |
Significant ΦST values are in bold after FDR testing (P < 0.05).